Search Reports :

Insulin Delivery Systems Market Analysis (2007-2010)

Share |
Publish Date:  Feb, 2008   New Report Available No. of Pages: 125
Format: Adobe Reader (PDF) Upto 24 hour delivery
Insulin Delivery Systems Market Analysis (2007-2010)
  Electronic Access - Single User License   US$ 1400.00
  CD-ROM Mail Delivery   US$ 1700.00
  Hard Copy Mail Delivery   US$ 1700.00
  Electronic Access - Multi-User License   US$ 2000.00
Description Table of Content
List of Figures & Tables

List of Figures:
 
Figure 3-1: Global - Overweight & Obese Population (in Billion), 2005, 2007E & 2015E
Figure 4-1: Global - Number of Diabetic Patients (in Million), 2003 & 2007
Figure 4-2: Global - Diabetes Drugs Market (in Billion US$), 2004-2006
Figure 4-3: Global - Insulin Market (in Billion US$), 2005 & 2006
Figure 4-4: India - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-5: India - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-6: India - Insulin Market (in Billion INR), 2003 & 2006
Figure 4-7: India - Share of Key Players in Insulin Market (%), 2004
Figure 4-8: China - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-9: China - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-10: China - Insulin Market (in Billion RMB), 2005, 2006E & 2012F
Figure 4-11: China - Share of Key Players in Insulin Market (%), 2004*
Figure 4-12: US - Diabetic Patients in Age Group 20-79 Years (in ‘000), 2003-2006E
Figure 4-13: US - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-14: US - Insulin Market (in Billion US$), 2003-2006E
Figure 4-15: US - Share of Key Players in Insulin Market (%), 2006
Figure 4-16: Russia - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-17: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-18: Russia - Insulin Market (in Million US$), 2005-2008E
Figure 4-19: Russia - Share of Key Players in Insulin Market (%), 2005
Figure 4-20: Russia - Share of Sales Channel in Insulin Market (%), 2005
Figure 4-21: Japan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-22: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-23: Japan - Insulin Market (in Billion JPY), 2004-2006E & 2012F
Figure 4-24: Japan - Share of Novo Nordisk in Insulin Market (%), 2006*
Figure 4-25: Germany - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-26: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-27: Germany - Insulin Market (in Billion US$), 2005-2007E
Figure 4-28: Pakistan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-29: Pakistan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-30: Brazil - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-31: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-32: Brazil - Insulin Market (in Million US$), 2000E, 2006 & 2010E
Figure 4-33: Mexico - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-34: Mexico - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-35: Egypt - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-36: Egypt - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 5-1: Global, US, Europe & Japan - Insulin Units Delivered through Pen Devices (%), 2006
Figure 5-2: US - Insulin Pen Devices Market (in Million US$), 2003-2006E
Figure 5-3: US - Insulin Pen Devices Market (in Million US$), 2007-2010F
Figure 5-4: US - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-5: US - Volume Share of Disposable & Refillable Pen Devices (%), 2006
Figure 5-6: Europe - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-7: Europe - Volume Share of Disposable & Refillable Pen Devices (%), 2006
Figure 5-8: Japan - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-9: Global - Share of Key Players in Pen Devices Market (%), 2005
Figure 5-10: Global - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-11: Global - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-12: Global - Share of US & Non-US Markets in Insulin Pumps & Disposables Market (%), 2002-2006E
Figure 5-13: Global - Share of US & Non-US Markets in Insulin Pumps & Disposables Market (%), 2007-2009F
Figure 5-14: US - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-15: US - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-16: US - Share of Insulin Pumps & Disposables in Market (%), 2002-2006E
Figure 5-17: US - Share of Insulin Pumps & Disposables in Market (%), 2007-2009F
Figure 5-18: US - Sales of Insulin Pumps (in ‘000 Units), 2002-2006E
Figure 5-19: US - Sales of Insulin Pumps (in ‘000 Units), 2007-2009F
Figure 5-20: US - Sales of New & Replacement Insulin Pumps (in ‘000 Units), 2002-2006E
Figure 5-21: US - Sales of New & Replacement Insulin Pumps (in ‘000 Units), 2007-2009F
Figure 5-22: US - Cumulative Sales of New Insulin Pumps (in ‘000 Units) 2007-2009F
Figure 5-23: US - Cumulative Sales of New Insulin Pumps for Type 1 & Type 2 Patients (in ‘000 Units), 2002-2006E
Figure 5-24: US - Cumulative Sales of New Insulin Pumps for Type 1 & Type 2 Patients (in ‘000 Units), 2007-2009F
Figure 5-25: US - Cumulative Penetration of Type 1 & Type 2 Patients using Insulin Pumps (%), 2002-2006E
Figure 5-26: US - Cumulative Penetration of Type 1 & Type 2 Patients using Insulin Pumps (%), 2007-2009F
Figure 5-27: US - Users Discontinuing Use of Insulin Pumps (%), 2002-2006E
Figure 5-28: US - Users Discontinuing Use of Insulin Pumps (%), 2007-2009F
Figure 5-29: Non-US - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-30: Non-US - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-31: Global - Share of Key Players in Insulin Pumps Market (%), 2002-2006E
Figure 5-32: Global - Share of Key Players in Insulin Pumps Market (%), 2007-2009F
Figure 5-33: US - Share of Key Players in Insulin Pumps Market (%), 2002-2006E
Figure 5-34: US - Share of Key Players in Insulin Pumps Market (%), 2007-2009F
Figure 5-35: Europe - Share of Key Players in Insulin Pumps Market (%), 2004
Figure 5-36: Japan - Share of Nipro in Insulin Pumps Market (%), 2005
Figure 5-37: Global - Sales of Exubera (in Million US$), 2006*, 2007** & 2015F
Figure 5-38: Global - Forecast for Sales of Exubera, Technosphere, Air System & Aerx-iDMS (in Million US$), 2015
Figure 5-39: Global - Forecast for Share of Inhalable Insulin (%), 2015
Figure 5-40: US - Insulin Syringes Market (in Million US$), 2003-2006E
Figure 5-41: US - Share of Insulin Syringes Market (%), 2003-2006E
Figure 5-42: US - Forecast for Insulin Syringes Market (in Million US$), 2007-2010
Figure 5-43: US - Forecast for Share of Insulin Syringes Market (%), 2007-2010
Figure 5-44: Global - Jet Injectors & Insulin-driven Jet Injectors Market (in Million US$), 2003-2006E
Figure 5-45: US - Insulin-driven Jet Injectors Market (in Million US$), 2003-2006E
Figure 5-46: US - Share of Insulin-driven Jet Injectors Market (%), 2003-2006E
Figure 5-47: Global - Forecast for Insulin-driven Jet Injectors Market (in Million US$), 2007-2010
Figure 5-48: US - Forecast for Insulin-driven Jet Injectors Market (in Million US$), 2007-2010
Figure 5-49: US - Forecast for Share of Insulin-driven Jet Injectors Market (%), 2007-2010
Figure 7-1: Global - Forecast for Number of Diabetic Patients (in Million), 2013, 2019 & 2025
Figure 7-2: Global - Forecast for Diabetes Drugs Market (in Billion US$), 2007-2012
Figure 7-3: Global - Forecast for Insulin Market (in Billion US$), 2007-2012
Figure 7-4: Global - Insulin Demand (in Kg), 2006 & 2012F

List of Tables:

Table 2-1: Global - Top 10 Countries with Maximum Diabetic Population in Age Group 20-79 Years (in Million), 2003 & 2025F
Table 3-1: Global - Percentage of Overweight Population by Leading Countries (2006)
Table 3-2: Global - Percentage of Diabetic Population by Leading Countries (2003)
Table 4-1: Global - List of Top 10 Anti-diabetic Brands, 2005
Table 4-2: India - Diabetic Patients in Age Group 20-79 Years (in ‘000), 2003
Table 4-3: India - Forecast for Diabetic Patients in Age Group 20-79 Years (in ‘000), 2025
Table 4-4: China - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-5: China - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-6: US - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-7: US - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-8: Russia - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-9: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-10: Japan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-11: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-12: Germany - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-13: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-14: Pakistan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-15: Pakistan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-16: Brazil - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-17: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-18: Mexico - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-19: Mexico - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-20: Egypt - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-21: Egypt - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 5-1: Characteristics of Various Inhalable Insulin Products
Table 8-1: Eli Lilly & Company - Key Financials (in Million US$), 2004-2006
Table 8-2: Novo Nordisk A/S - Key Financials (in Million US$), 2004-2006
Table 8-3: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
Table 8-4: Becton, Dickinson and Company - Key Financials (in Million US$), 2005-2007
Table 8-5: Medtronic, Inc. - Key Financials (in Million US$), 2005-2007

Not able to find data you are looking for? Ask our Research Analyst.

All Research Reports

- Healthcare Industry (46)

   - Pharma (16)

   - Biotech (7)

   - Healthcare (17)

   - Vaccine (2)

   - Generics (4)

 

Related Reports

- Global Vaccine Market Out...
- Booming Clinical Trials M...
- World Pharmaceutical Mark...
 
Related Research News
Jan 25, 2010
Dec 30, 2009
Nov 15, 2009
Oct 21, 2009
Related Press Releases
Mar 18, 2010
Mar 18, 2010
Mar 17, 2010
Mar 03, 2010
Email Subscription
Receive email alerts of new market research report in your industry.

Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL
Copyright © 2010, RNCOS, 2002-2010
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707